Cervical premalignant lesions and their management

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer ranks as the tenth most common cancer in developed nations with screening programs, but second in underdeveloped countries.
• In Turkey, it is the eighth most prevalent cancer among women, highlighting the need for effective screening.
• Periodic cervical cancer screening is crucial for identifying and managing preinvasive lesions, preventing progression to invasive disease.

Purpose of the Study:

• To emphasize the importance of cervical cancer screening programs.
• To highlight the role of the human papilloma virus (HPV) vaccine in cervical cancer prevention.
• To guide obstetrics and gynecology specialists in managing preinvasive cervical lesions effectively.

Main Methods:

• Review of current cervical cancer screening methods, focusing on cervical smears.
• Discussion of the impact of the human papilloma virus (HPV) vaccine on prevention strategies.
• Analysis of management protocols for preinvasive cervical lesions.

Main Results:

• Effective screening programs significantly reduce invasive cervical cancer rates.
• The HPV vaccine offers new insights into cervical cancer prevention.
• Correct management of preinvasive lesions avoids unnecessary procedures and treatments.

Conclusions:

• Accurate diagnosis and appropriate management of preinvasive cervical lesions are essential.
• Histological diagnosis should precede ablative or destructive treatments.
• Hysterectomy should not be recommended for preinvasive lesions due to recurrence risks.